Found 62 matching trials
A Phase III Study of Ivonescimab + Chemo With/Without AK117 in Metastatic Pancreatic Cancer
PHASE3This is a Phase 3, randomized, double-blind clinical trial aimed at evaluat...
Location
Harbin Medical University Cancer Hospital
Adapted Guided Stereotactic Body Radiotherapy Combined With Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND)
PHASE1This study aims to evaluate the safety and efficacy of Ivonescimab, a bispe...
Location
Shandong Cancer Hospital and Institute
A Phase II Study of Ivonescimab Combined with Cadonilimab and Chemotherapy in Extensive-stage Small Cell Lung Cancer
PHASE2The goal of this clinical trial is to investigate the efficacy, safety and ...
Location
Multiple Locations
Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma(uHCC).
PHASE2This study is a single-center, open-label Phase II clinical trial, aiming t...
Location
Tianjin Cancer Hospital Airport Hospital
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
PHASE2The purpose of this study is to establish a prospective, single-center plat...
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Phase 3 Clinical Study of AK112 for NSCLC Patients
PHASE3A Randomized, Double-blind, Multi-center, Phase III Clinical Study of AK112...
Status
Active Not Recruiting
Location
Sun Yat-sen University Cancer Center
Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer
PHASE2Neoadjuvant ChemoRadioTherapy (NCRT) combined with surgical resection is th...
Location
Tianjin Medical University Cancer Hospital
Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
PHASE2This study is an open-label, single-arm Phase II clinical study to evaluate...
Location
Wuhan Union Hospital of China
Ivonescimab in Combination With Liposomal Irinotecan and 5-FU/LV in Potentially Resectable Biliary Tract Malignancies
PHASE2This Phase II, single-arm, single-center study evaluates the conversion to ...
Location
Tianjin Medical University Cancer Institute & Hospital
Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma
PHASE2In the past few decades, surgery, radiotherapy, chemotherapy and other trea...
Location
The Second Affiliated Hospital of Zhejiang University